ELEM pioneers industrial-scale high-throughput in vitro cell editing platforms, covering gene-edited cells required for drug screening and fundamental research
Advanced automation solutions for high-throughput gene editing workflows, from RNP delivery to single-cell cloning verification
For gene knockout, ELEM provides one-stop services from plasmid to cell editing support, using our proprietary high-efficiency gene editing system
ELEM Biotech is an innovative technology company specializing in high-throughput cell editing technology. We possess advanced high-throughput CRISPR/Cas9 technology platforms and an experienced service team, dedicated to providing high-quality comprehensive gene editing solutions to research institutions and pharmaceutical companies worldwide.
In the biopharmaceutical field where time is life, we deeply understand the importance of speed. Through standardized and automated processes, we shorten the editing cycle from months to weeks.
With powerful production capacity of 1000+ KO cell pools per month, we have completed knockout validation of all 19,883 genes in the human genome.
High-Throughput Cell Editing — Virtual Knockout — Virtual Cell
“ELEM Biotech's high-throughput gene editing platform has significantly accelerated our drug screening process. Their rigorous quality control system gives us full confidence in experimental results. Every batch of cells undergoes dual DNA and protein validation, ensuring data reliability. From project initiation to delivery took only two weeks, far exceeding our expectations.”
“As basic researchers, we have extremely high quality requirements for experimental materials. ELEM Biotech's KO cell pools not only have a success rate exceeding 90%, but are also completely mycoplasma-free. Their BSL-2 laboratory standards and strict environmental monitoring give our research data extremely high reproducibility. Three years of cooperation, very satisfied!”